Fortis Capital Management LLC Edwards Lifesciences Corp Transaction History

Fortis Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$71.69 - $91.23 $1.72 Million - $2.19 Million	-24,000 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$67.19 - $87.44 $123,360 - $160,539	-1,836 Reduced 7.11%	24,000 $1.92 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $1.49 Million - $1.99 Million	25,836 New	25,836 $1.79 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Fortis Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Fortis Capital Management LLC with notifications on news.